La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Atomo Diagnostics Dividende

Dividende contrôle des critères 0/6

Atomo Diagnostics does not have a record of paying a dividend.

Informations clés

n/a

Rendement du dividende

n/a

Ratio de distribution

Rendement moyen de l'industrie	1.6%
Prochaine date de paiement du dividende	n/a
Date ex-dividende	n/a
Dividende par action	n/a
Résultat par action	-AU$0.012
Prévisions de rendement du dividende à 3 ans	n/a

Mises à jour récentes des dividendes

Pas de mise à jour

Recent updates

Atomo Diagnostics Limited (ASX:AT1) Shares Could Be 50% Below Their Intrinsic Value Estimate

Nov 01

We're Interested To See How Atomo Diagnostics (ASX:AT1) Uses Its Cash Hoard To Grow

Jul 19

Market Sentiment Around Loss-Making Atomo Diagnostics Limited (ASX:AT1)

Feb 26

Atomo Diagnostics (ASX:AT1) Is In A Strong Position To Grow Its Business

Jan 22

Here's What Atomo Diagnostics Limited's (ASX:AT1) Shareholder Ownership Structure Looks Like

Dec 18

When Can We Expect A Profit From Atomo Diagnostics Limited (ASX:AT1)?

Jul 16

Stabilité et croissance des paiements

Récupération des données sur les dividendes

Dividende stable: Données insuffisantes pour déterminer si les dividendes par action de AT1 ont été stables dans le passé.

Dividende croissant: Insufficient data to determine if AT1's dividend payments have been increasing.

Rendement des dividendes par rapport au marché

Atomo Diagnostics Rendement des dividendes par rapport au marché

Comment le rendement du dividende de AT1 se compare-t-il à celui du marché ?
Segment	Rendement du dividende
Entreprise (AT1)	n/a
25% du marché (AU)	2.6%
25% du marché (AU)	6.1%
Moyenne du secteur (Medical Equipment)	1.6%
Prévisions des analystes dans 3 ans (AT1)	n/a

Dividende notable: Unable to evaluate AT1's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Dividende élevé: Unable to evaluate AT1's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Bénéfice distribué aux actionnaires

Couverture des revenus: Insufficient data to calculate AT1's payout ratio to determine if its dividend payments are covered by earnings.

Paiement en espèces aux actionnaires

Couverture des flux de trésorerie: Unable to calculate sustainability of dividends as AT1 has not reported any payouts.

Atomo Diagnostics Dividende

Dividende contrôle des critères 0/6

Informations clés

Mises à jour récentes des dividendes

Recent updates

New minor risk - Share price stability

Atomo Diagnostics Limited to Report Fiscal Year 2024 Results on Aug 30, 2024

Atomo Diagnostics Limited to Report First Half, 2024 Results on Jan 29, 2024

Atomo Diagnostics Limited Announces the Resignation of Curt LaBelle as Non-Executive Director

Atomo Diagnostics Limited Announces the Departure of William Souter as Chief Financial Officer, Effective 13 December 2023

Atomo Diagnostics Limited Announces the Departure of William Souter as Chief Financial Officer, Effective 13 December 2023

New major risk - Market cap size

Full year 2023 earnings released: AU$0.017 loss per share (vs AU$0.01 loss in FY 2022)

Atomo Diagnostics Limited, Annual General Meeting, Nov 02, 2023

We Think Atomo Diagnostics (ASX:AT1) Can Afford To Drive Business Growth

New major risk - Share price stability

Atomo Diagnostics Limited to Report Q4, 2023 Results on Jul 31, 2023

First half 2023 earnings released: AU$0.01 loss per share (vs AU$0.004 loss in 1H 2022)

Atomo Diagnostics Limited Appoints Cheri Walker as an Independent Non-Executive Director

We Think Atomo Diagnostics (ASX:AT1) Can Afford To Drive Business Growth

Atomo Diagnostics Limited, Annual General Meeting, Oct 27, 2022

No longer forecast to breakeven

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Is Atomo Diagnostics (ASX:AT1) In A Good Position To Invest In Growth?

Forecast breakeven date pushed back to 2024

Atomo Diagnostics Limited Expands Executive Team

No longer forecast to breakeven

First half 2022 earnings: EPS misses analyst expectations

Price target decreased to AU$0.31

Atomo Diagnostics Limited to Report First Half, 2022 Results on Feb 21, 2022

Atomo Diagnostics Limited Receives Approval for its Covid-19 Antigen Test in NZ

We're Not Worried About Atomo Diagnostics' (ASX:AT1) Cash Burn

Atomo Diagnostics Limited (ASX:AT1) Shares Could Be 50% Below Their Intrinsic Value Estimate

Full year 2021 earnings released

Consensus revenue estimates fall to AU$7.20m

Forecast breakeven pushed back to 2023

We're Interested To See How Atomo Diagnostics (ASX:AT1) Uses Its Cash Hoard To Grow

Consensus revenue estimates fall to AU$9.60m

Market Sentiment Around Loss-Making Atomo Diagnostics Limited (ASX:AT1)

First half 2021 earnings released: AU$0.005 loss per share (vs AU$0.008 loss in 1H 2020)

Revenue and earnings beat expectations

New 90-day low: AU$0.28

Atomo Diagnostics (ASX:AT1) Is In A Strong Position To Grow Its Business

New 90-day low: AU$0.29

Here's What Atomo Diagnostics Limited's (ASX:AT1) Shareholder Ownership Structure Looks Like

New 90-day low: AU$0.30

Atomo Diagnostics Limited Receives TGA Approval for Atomorapid HIV (1&2) Test

Atomo Diagnostics Limited Receives TGA Approval for Covid19 Antigen Test

New 90-day low: AU$0.33

Atomo Diagnostics Limited Expands Its Existing COVID-19 Rapid Test Partnership with Access Bio LLC

Atomo Diagnostics Limited Enters into an Agreement DIVOC Laboratories to Launch its COVID-19 Antibody Test in the Indian Market

Full year earnings released - AU$0.026 loss per share

Atomo Diagnostics Limited to Report Fiscal Year 2020 Final Results on Nov 02, 2020

New 90-day high - AU$0.45

Atomo Diagnostics Limited to Report Fiscal Year 2020 Results on Aug 31, 2020

When Can We Expect A Profit From Atomo Diagnostics Limited (ASX:AT1)?

Stabilité et croissance des paiements

Rendement des dividendes par rapport au marché

Bénéfice distribué aux actionnaires

Paiement en espèces aux actionnaires

Découvrir des entreprises qui versent des dividendes élevés